RxDoctor Payments DataLook up a doctor →

Christine Rocks-Lopez

Primary Care · Phoenix, AZNPI 1639553548

Payments from drug & device makers

$13,521in general payments, 2019–2025

Across 596 payments — averaging $22.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$1K
  • Novo Nordisk$1K
  • Biohaven Pharmaceuticals, Inc.$1K
  • Amgen$828
  • Lilly USA, LLC$652
  • plus $6K from 52 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie131$1,966
AstraZeneca27$1,469
Novo Nordisk49$1,190
Biohaven Pharmaceuticals, Inc.16$1,159
Amgen36$828
Lilly USA, LLC42$652
Pfizer31$620
Abbott23$560
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC29$451
Bayer20$448
Biohaven Pharmaceutical Holding Company Ltd.17$417
Astellas Pharma US Inc10$358
Axsome Therapeutics, Inc.9$278
QOL Medical, LLC2$245
Boehringer Ingelheim14$243
GSK14$234
Sanofi-aventis U.S. LLC10$169
Daiichi Sankyo Inc.5$168
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)11$145
Inspire Medical Systems, Inc.5$140
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)3$133
Antares Pharma, Inc.8$131
Merck6$104
Amarin Pharma, Inc.6$103
Alfasigma USA, Inc.5$96
Teva Pharmaceuticals USA, Inc.5$84
Boston Scientific4$77
Kowa Pharmaceuticals America, Inc.5$76
Sumitomo Pharma America, Inc.3$75
Novartis4$74
Phathom Pharmaceuticals, Inc.4$71
Johnson & Johnson4$59
Esperion Therapeutics, Inc.3$55
Nevro Corp.2$50
Gilead3$49
Takeda Pharmaceuticals U.S.A., Inc.3$47
Almatica Pharma LLC2$46
Eisai Inc.2$44
Hologic Sales And Service, LLC2$39
Impulse Dynamics (USA) Inc.2$35
Currax Pharmaceuticals LLC2$27
Spinal Simplicity, LLC1$27
Actelion Pharmaceuticals US, Inc.1$23
Nalu Medical, Inc.1$21
Paratek Pharmaceuticals, Inc.1$21
Radius Health, Inc.1$20
Phadia US Inc.1$20
Seqirus USA Inc1$19
Painteq LLC1$18
Nestle Healthcare Nutrition Inc.1$18
Exeltis, USA Inc.1$16
Halozyme Inc1$15
Noven Therapeutics, LLC1$15
Medtronic1$15
Ascensia Diabetes Care US Inc.1$15
Sanofi Pasteur Inc.1$14
Tolmar, Inc.1$14
Exact Sciences1$13

How this compares

$13,521 in reported general payments places this provider in the 95th percentile of 151 primary care providers in Arizona.

See all primary care providers in Arizona →

Medicare billing

Part B allowed, 2024
$75,732
Medicare patients
136
Services billed
1,615

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other primary care in Phoenix

See the full list for Arizona →

Where these figures come from

Is this you, or does something look wrong? →